HTD2
gene geneOn this page
Summary
HTD2 (hydroxyacyl-thioester dehydratase type 2, HGNC:53111) is a protein-coding gene on chromosome 3p14.3, encoding Hydroxyacyl-thioester dehydratase type 2, mitochondrial (P86397). Mitochondrial 3-hydroxyacyl-thioester dehydratase, which may be involved in fatty acid biosynthesis.
This gene encodes a protein that localizes to the mitochondria and can function as a 3-hydroxyacyl thioester dehydratase. This gene is located just downstream of the gene for ribonuclease P/MRP subunit p14 (RPP14) in a genomic context that is conserved among animals. The upstream RPP14 gene is thought to be co-transcribed with this gene, and bicistronic transcripts may include open reading frames for both proteins.
Source: NCBI Gene 109703458 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 29 total
- MANE Select transcript:
NM_001348712
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:53111 |
| Approved symbol | HTD2 |
| Name | hydroxyacyl-thioester dehydratase type 2 |
| Location | 3p14.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000255154 |
| Ensembl biotype | protein_coding |
| OMIM | 620769 |
| Entrez | 109703458 |
Gene structure
Transcript identifiers
Ensembl transcripts: 7 — 6 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000461393, ENST00000474660, ENST00000475412, ENST00000476007, ENST00000477305, ENST00000481972, ENST00000498618
RefSeq mRNA: 4 — MANE Select: NM_001348712
NM_001348712, NM_001348713, NM_001348714, NM_001348715
CCDS: CCDS87096
Canonical transcript exons
ENST00000461393 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001849775 | 58317440 | 58320193 |
| ENSE00001897116 | 58306520 | 58306651 |
| ENSE00003724072 | 58316515 | 58316591 |
| ENSE00003741711 | 58316915 | 58316993 |
| ENSE00003746656 | 58310507 | 58310591 |
Expression profiles
Bgee: expression breadth ubiquitous, 134 present calls, max score 90.13.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 8.0521 / max 110.7990, expressed in 1774 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 37039 | 8.0521 | 1774 |
| 37040 | 6.9940 | 1740 |
Top tissues by expression
134 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 90.13 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 88.50 | gold quality |
| muscle of leg | UBERON:0001383 | 84.85 | gold quality |
| gastrocnemius | UBERON:0001388 | 84.43 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 83.98 | gold quality |
| muscle tissue | UBERON:0002385 | 82.70 | gold quality |
| duodenum | UBERON:0002114 | 81.44 | gold quality |
| islet of Langerhans | UBERON:0000006 | 80.96 | gold quality |
| heart left ventricle | UBERON:0002084 | 80.83 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 80.60 | gold quality |
| rectum | UBERON:0001052 | 80.16 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 80.01 | gold quality |
| heart | UBERON:0000948 | 79.47 | gold quality |
| apex of heart | UBERON:0002098 | 78.84 | gold quality |
| right atrium auricular region | UBERON:0006631 | 78.63 | gold quality |
| stromal cell of endometrium | CL:0002255 | 78.41 | gold quality |
| prefrontal cortex | UBERON:0000451 | 78.02 | gold quality |
| adrenal tissue | UBERON:0018303 | 77.93 | gold quality |
| placenta | UBERON:0001987 | 77.72 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 77.57 | gold quality |
| ventricular zone | UBERON:0003053 | 77.56 | gold quality |
| gall bladder | UBERON:0002110 | 77.27 | gold quality |
| leukocyte | CL:0000738 | 77.13 | gold quality |
| monocyte | CL:0000576 | 76.90 | gold quality |
| vermiform appendix | UBERON:0001154 | 76.54 | gold quality |
| granulocyte | CL:0000094 | 76.53 | gold quality |
| lymph node | UBERON:0000029 | 76.47 | gold quality |
| endometrium | UBERON:0001295 | 76.37 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 76.22 | gold quality |
| adrenal gland | UBERON:0002369 | 76.10 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.12 |
Regulation
Is transcription factor: no
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Htd2 | ENSMUSG00000144287 |
| rattus_norvegicus | Rpp14 | ENSRNOG00000063660 |
Protein
Protein identifiers
Hydroxyacyl-thioester dehydratase type 2, mitochondrial — P86397 (reviewed: P86397)
Alternative names: 3-hydroxyacyl-[acyl-carrier-protein] dehydratase
All UniProt accessions (5): A0A087WTC8, A0A087WUW1, A0A087WYB6, P86397, L0R6P0
UniProt curated annotations — full annotation on UniProt →
Function. Mitochondrial 3-hydroxyacyl-thioester dehydratase, which may be involved in fatty acid biosynthesis.
Subcellular location. Mitochondrion.
Tissue specificity. Highly expressed in heart and liver. Expressed at lower levels in skeletal muscle, spleen, kidney and placenta.
Miscellaneous. This protein is produced by a bicistronic gene which also produces the RPP14 protein from an overlapping reading frame.
Similarity. Belongs to the HTD2 family.
RefSeq proteins (4): NP_001335641, NP_001335642, NP_001335643, NP_001335644 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002539 | MaoC-like_dom | Domain |
| IPR029069 | HotDog_dom_sf | Homologous_superfamily |
| IPR050965 | UPF0336/Enoyl-CoA_hydratase | Family |
Pfam: PF01575
Catalyzed reactions (Rhea), 3 shown:
- a (3R)-hydroxyacyl-[ACP] = a (2E)-enoyl-[ACP] + H2O (RHEA:13097)
- (3R)-hydroxyhexanoyl-[ACP] = (2E)-hexenoyl-[ACP] + H2O (RHEA:41828)
- (3R)-hydroxydecanoyl-[ACP] = (2E)-decenoyl-[ACP] + H2O (RHEA:41860)
UniProt features (14 total): strand 5, helix 3, mutagenesis site 2, transit peptide 1, chain 1, turn 1, domain 1
Structure
Experimental structures (PDB)
1 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 3IR3 | X-RAY DIFFRACTION | 1.99 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P86397-F1 | 84.54 | 0.74 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Mutagenesis-validated functional residues (2):
| Position | Phenotype |
|---|---|
| 62 | abolishes ability to complement a htd2-delta mutant yeast. |
| 67 | abolishes ability to complement a htd2-delta mutant yeast. |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-75105 | Fatty acyl-CoA biosynthesis |
MSigDB gene sets: 67 (showing top):
GOBP_ORGANOPHOSPHATE_METABOLIC_PROCESS, GOBP_NUCLEOSIDE_PHOSPHATE_BIOSYNTHETIC_PROCESS, GOBP_MONOCARBOXYLIC_ACID_METABOLIC_PROCESS, GOBP_ORGANOPHOSPHATE_BIOSYNTHETIC_PROCESS, GOBP_ORGANIC_ACID_BIOSYNTHETIC_PROCESS, GOBP_NUCLEOBASE_CONTAINING_SMALL_MOLECULE_METABOLIC_PROCESS, GOBP_SMALL_MOLECULE_BIOSYNTHETIC_PROCESS, GOBP_FATTY_ACYL_COA_METABOLIC_PROCESS, GOBP_SULFUR_COMPOUND_BIOSYNTHETIC_PROCESS, GOBP_AMIDE_METABOLIC_PROCESS, GOBP_AMIDE_BIOSYNTHETIC_PROCESS, GOBP_FATTY_ACID_BIOSYNTHETIC_PROCESS, GOBP_MONOCARBOXYLIC_ACID_BIOSYNTHETIC_PROCESS, GOBP_LIPID_METABOLIC_PROCESS, GOBP_ORGANIC_ACID_METABOLIC_PROCESS
GO Biological Process (4): fatty acid biosynthetic process (GO:0006633), fatty-acyl-CoA biosynthetic process (GO:0046949), lipid metabolic process (GO:0006629), fatty acid metabolic process (GO:0006631)
GO Molecular Function (4): 3-hydroxyacyl-CoA dehydratase activity (GO:0018812), (3R)-hydroxyacyl-[acyl-carrier-protein] dehydratase activity (GO:0019171), lyase activity (GO:0016829), hydro-lyase activity (GO:0016836)
GO Cellular Component (3): nucleolus (GO:0005730), mitochondrion (GO:0005739), mitochondrial matrix (GO:0005759)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Fatty acid metabolism | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| fatty acid metabolic process | 1 |
| lipid biosynthetic process | 1 |
| monocarboxylic acid biosynthetic process | 1 |
| fatty-acyl-CoA metabolic process | 1 |
| acyl-CoA biosynthetic process | 1 |
| fatty acid derivative biosynthetic process | 1 |
| primary metabolic process | 1 |
| lipid metabolic process | 1 |
| monocarboxylic acid metabolic process | 1 |
| enoyl-CoA hydratase activity | 1 |
| hydro-lyase activity | 1 |
| catalytic activity | 1 |
| carbon-oxygen lyase activity | 1 |
| nuclear lumen | 1 |
| intracellular membraneless organelle | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
| mitochondrion | 1 |
| intracellular organelle lumen | 1 |
Protein interactions and networks
STRING
974 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| HTD2 | OXSM | Q9NWU1 | 458 |
| HTD2 | MCAT | Q8IVS2 | 456 |
| HTD2 | CHCHD1 | Q96BP2 | 446 |
| HTD2 | RPP38 | P78345 | 443 |
| HTD2 | SLC35A4 | Q96G79 | 433 |
| HTD2 | DMAC2 | Q9NW81 | 426 |
| HTD2 | POP1 | Q99575 | 419 |
| HTD2 | MRPL42 | Q9Y6G3 | 410 |
| HTD2 | UQCC3 | Q6UW78 | 403 |
| HTD2 | ACAA1 | P09110 | 394 |
| HTD2 | DEFA4 | P12838 | 380 |
| HTD2 | LIPT2 | A6NK58 | 367 |
| HTD2 | MECR | Q9BV79 | 364 |
| HTD2 | ZNF708 | P17019 | 359 |
| HTD2 | SLC35F6 | Q8N357 | 353 |
| HTD2 | SCP2 | P22307 | 353 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| HSCB | RBP5 | psi-mi:“MI:0914”(association) | 0.350 |
ESM2 similar proteins: A0A1D6NER6, A0A3Q7HWE4, A4GNA8, B7TWW5, F4HU51, F4JTE7, F4JYE9, F4JZC2, M4IS90, O48651, O65090, O81000, O82497, O82796, P34419, P51660, P55228, P55232, P86397, P87304, P97852, Q07G10, Q0WW55, Q338C0, Q5FYU1, Q6DRD9, Q6GLK2, Q6JQN1, Q6NMK6, Q8BH55, Q8H151, Q8H4D4, Q8K370, Q8LEA0, Q8VYI3, Q8VZ10, Q8W471, Q93WU4, Q93Z01, Q944R7
Diamond homologs: A0A3Q7HWE4, C5AZ74, O32472, P49251, P86397, P9WNP2, P9WNP3, Q2RQ36, Q7U2S5, Q9FJI2, Q9VXJ0, P51659, P51660, P97852, Q01373, Q8VYI3, P22414, Q02207, P77455
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
29 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 18 |
| Likely benign | 0 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
854 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 3:58310496:A:AG | acceptor_gain | 1.0000 |
| 3:58310497:C:G | acceptor_gain | 1.0000 |
| 3:58310502:TTTA:T | acceptor_loss | 1.0000 |
| 3:58310505:A:AG | acceptor_gain | 1.0000 |
| 3:58310505:A:T | acceptor_loss | 1.0000 |
| 3:58310506:G:GA | acceptor_gain | 1.0000 |
| 3:58310506:GA:G | acceptor_gain | 1.0000 |
| 3:58310506:GAGA:G | acceptor_gain | 1.0000 |
| 3:58310506:GAGAA:G | acceptor_gain | 1.0000 |
| 3:58310589:G:GT | donor_gain | 1.0000 |
| 3:58310589:G:T | donor_gain | 1.0000 |
| 3:58310589:GAGG:G | donor_loss | 1.0000 |
| 3:58310591:GGTA:G | donor_loss | 1.0000 |
| 3:58316587:AGCAG:A | donor_loss | 1.0000 |
| 3:58316589:CAGGT:C | donor_loss | 1.0000 |
| 3:58316590:AGG:A | donor_loss | 1.0000 |
| 3:58316591:GGTA:G | donor_loss | 1.0000 |
| 3:58316592:GTATG:G | donor_loss | 1.0000 |
| 3:58316593:T:A | donor_loss | 1.0000 |
| 3:58316913:A:AG | acceptor_gain | 1.0000 |
| 3:58316913:AGT:A | acceptor_gain | 1.0000 |
| 3:58316914:G:GA | acceptor_gain | 1.0000 |
| 3:58316914:GT:G | acceptor_gain | 1.0000 |
| 3:58316914:GTG:G | acceptor_gain | 1.0000 |
| 3:58310577:G:GT | donor_gain | 0.9900 |
| 3:58310587:GGGAG:G | donor_gain | 0.9900 |
| 3:58310588:GGAG:G | donor_gain | 0.9900 |
| 3:58310588:GGAGG:G | donor_gain | 0.9900 |
| 3:58310589:GAG:G | donor_gain | 0.9900 |
| 3:58316510:TGCA:T | acceptor_loss | 0.9900 |
AlphaMissense
1092 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 3:58317953:T:C | F114L | 0.996 |
| 3:58317955:T:A | F114L | 0.996 |
| 3:58317955:T:G | F114L | 0.996 |
| 3:58317779:T:C | F56L | 0.994 |
| 3:58317781:C:A | F56L | 0.994 |
| 3:58317781:C:G | F56L | 0.994 |
| 3:58317756:T:C | F48S | 0.989 |
| 3:58318071:T:A | V153D | 0.987 |
| 3:58317799:T:A | D62E | 0.986 |
| 3:58317799:T:G | D62E | 0.986 |
| 3:58317861:T:A | V83E | 0.986 |
| 3:58317990:C:A | A126D | 0.986 |
| 3:58317995:G:C | A128P | 0.986 |
| 3:58317755:T:C | F48L | 0.985 |
| 3:58317757:C:A | F48L | 0.985 |
| 3:58317757:C:G | F48L | 0.985 |
| 3:58317797:G:C | D62H | 0.985 |
| 3:58317798:A:T | D62V | 0.985 |
| 3:58317954:T:C | F114S | 0.985 |
| 3:58317984:T:A | V124D | 0.985 |
| 3:58318043:T:C | C144R | 0.984 |
| 3:58318079:G:C | G156R | 0.984 |
| 3:58317845:T:C | F78L | 0.983 |
| 3:58317847:T:A | F78L | 0.983 |
| 3:58317847:T:G | F78L | 0.983 |
| 3:58317805:T:A | N64K | 0.982 |
| 3:58317805:T:G | N64K | 0.982 |
| 3:58317812:C:G | H67D | 0.982 |
| 3:58317954:T:G | F114C | 0.982 |
| 3:58318045:T:G | C144W | 0.982 |
dbSNP variants (sampled 300 via entrez): RS1000274592 (3:58308684 T>G), RS1000635913 (3:58312825 G>T), RS1000643635 (3:58316767 G>A,C), RS1000969611 (3:58317989 G>A,C,T), RS1000990659 (3:58318553 T>C,G), RS1001110062 (3:58311456 A>G), RS1001188625 (3:58313747 C>A), RS1001243426 (3:58307506 C>G), RS1001318525 (3:58307920 G>A), RS1001370830 (3:58308290 T>A), RS1001373520 (3:58320654 A>G), RS1001561457 (3:58311287 T>C), RS1001563995 (3:58304480 G>A), RS1001773346 (3:58309157 C>T), RS1001818262 (3:58320375 C>G)
Disease associations
OMIM: gene MIM:620769 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
3 total (human), top 3 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Smoke | decreases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
| S-Nitrosoglutathione | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.